In line with our on-going commitment to providing quality training and promoting the highest safety standard, Richmond Pharmacology are pleased to announce that our ILS Courses are now open to the public. In association with the Resuscitation Council UK, Richmond Pharmacology’s highly trained Resuscitation and Clinical Skills Practitioners will equip external healthcare professionals with the skills to assist patients in preventing or treating cardiac arrest.

To register your interest, or to find out more about the training offered by Richmond Pharmacology, please click here.Additionally, to find out more about the ILS training courses offered by the Resuscitation Council (UK), please check here.

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event